165
Views
0
CrossRef citations to date
0
Altmetric
Review

Recent advances in the treatment of gastrointestinal motility disorders in children

, , , , &
Pages 1285-1300 | Received 12 Apr 2023, Accepted 12 Dec 2023, Published online: 11 Jan 2024

References

  • Chanpong A, Borrelli O, Thapar N. Recent advances in understanding the roles of the enteric nervous system. Fac Rev. 2022;24(11):7. doi: 10.12703/r/11-7
  • Saliakellis E, Rybak A, Borrelli O. Esophageal Achalasia. In: Guandalini S Dhawan A, editors Textbook of pediatric gastroenterology, hepatology and nutrition: a comprehensive guide to practice. Cham: Springer International Publishing; 2022. p. 157–168.
  • Mayberry JF, Mayell MJ. Epidemiological study of achalasia in children. Gut. 1988;29(1):90–93. doi: 10.1136/gut.29.1.90
  • Marlais M, Fishman JR, Fell JM, et al. UK incidence of achalasia: an 11-year national epidemiological study. Arch Dis Child. 2011;96(2):192–194. doi: 10.1136/adc.2009.171975
  • Smits M, van Lennep M, Vrijlandt R, et al. Pediatric achalasia in the Netherlands: incidence, clinical course, and quality of life. J Pediatr. 2016;169:110–115.e3. doi: 10.1016/j.jpeds.2015.10.057
  • Kahrilas PJ, Boeckxstaens G. The spectrum of achalasia: lessons from studies of pathophysiology and high-resolution manometry. Gastroenterology. 2013;145(5):954–965. doi: 10.1053/j.gastro.2013.08.038
  • Liu X, Kuo E, Wang K, et al. Histologic findings in mucosa and muscularis propria biopsied during Peroral endoscopic myotomy in patients with achalasia. Gastroenterol Res. 2021;14(5):281–289. doi: 10.14740/gr1454
  • Sodikoff JB, Lo AA, Shetuni BB, et al. Histopathologic patterns among achalasia subtypes. Neurogastroenterol Motil. 2016;28(1):139–145. doi: 10.1111/nmo.12711
  • Ip KS, Cameron DJ, Catto-Smith AG, et al. Botulinum toxin for achalasia in children. J Gastroenterol Hepatol. 2000;15(10):1100–1104. doi: 10.1046/j.1440-1746.2000.02341.x
  • van Hoeij FB, Tack JF, Pandolfino JE, et al. Complications of botulinum toxin injections for treatment of esophageal motility disorders†. Dis Esophagus. 2017;30(3):1–5. doi: 10.1111/dote.12491
  • Di Nardo G, Rossi P, Oliva S, et al. Pneumatic balloon dilation in pediatric achalasia: efficacy and factors predicting outcome at a single tertiary pediatric gastroenterology center. Gastrointest Endosc. 2012;76(5):927–932. doi: 10.1016/j.gie.2012.06.035
  • Saliakellis E, Thapar N, Roebuck D, et al. Long-term outcomes of Heller’s myotomy and balloon dilatation in childhood achalasia. Eur J Pediatr. 2017;176(7):899–907. doi: 10.1007/s00431-017-2924-x
  • Vaos G, Demetriou L, Velaoras C, et al. Evaluating long-term results of modified Heller limited esophagomyotomy in children with esophageal achalasia. J Pediatr Surg. 2008;43(7):1262–1269. doi: 10.1016/j.jpedsurg.2008.02.074
  • Rebecchi F, Giaccone C, Farinella E, et al. Randomized controlled trial of laparoscopic Heller myotomy plus dor fundoplication versus Nissen fundoplication for achalasia: long-term results. Ann Surg. 2008;248(6):1023–1030. doi: 10.1097/SLA.0b013e318190a776
  • Jarzębicka D, Czubkowski P, Sieczkowska-Gołub J, et al. Achalasia in children—clinical presentation, diagnosis, long-term treatment outcomes, and quality of life. J Clin Med. 2021;10(17):3917. doi: 10.3390/jcm10173917
  • Pacilli M, Davenport M. Results of Laparoscopic Heller’s Myotomy for Achalasia in Children: A Systematic Review of the Literature. J Laparoendosc Adv Surg Tech A. 2017;27(1):82–90. doi: 10.1089/lap.2016.0169
  • Westermann C, Weller J, Patel P, et al. Evaluation of the surgical management of achalasia in children and young adults. J Surg Res. 2022;273:9–14. doi: 10.1016/j.jss.2021.12.004
  • Nicolas A, Aumar M, Tran LC, et al. Comparison of endoscopic dilatation and Heller’s myotomy for treating esophageal achalasia in children: a multicenter study. J Pediatr. 2022;251:134–139.e2. doi: 10.1016/j.jpeds.2022.07.010
  • Midya S, Ghosh D, Mahmalat MW. Fundoplication in laparoscopic Heller’s cardiomyotomy for achalasia. Cochrane Database Syst Rev. 2022;12(12):Cd013386. doi: 10.1002/14651858.CD013386.pub2
  • Provenzano L, Pulvirenti R, Duci M, et al. Laparoscopic Heller-Dor is a persistently effective treatment for achalasia even in pediatric patients: a 25-year experience at a single tertiary center. Eur J Pediatr Surg. 2023 Jan 31. Epub ahead of print. PMID: 36720247. doi: 10.1055/s-0043-1760822
  • Rossetti G, Brusciano L, Amato G, et al. A total fundoplication is not an obstacle to esophageal emptying after Heller myotomy for achalasia: results of a long-term follow up. Ann Surg. 2005 Apr;241(4):614–621.
  • Mattioli S, Ruffato A, Lugaresi M, et al. Long-term results of the Heller-Dor operation with intraoperative manometry for the treatment of esophageal achalasia. J Thorac Cardiovasc Surg. 2010 Nov;140(5):962–969. Epub 2010 Sep 9. PMID: 20828770.doi: 10.1016/j.jtcvs.2010.07.053
  • Tassi V, Lugaresi M, Pilotti V, et al. Outcomes of Heller Myotomy for esophageal achalasia: lessons from a 48-year prospective experience with 4 different techniques. Ann Surg. 2023 Jul 1;278(1):e27–e34. Epub 2022 Sep 9. PMID: 36082979. doi: 10.1097/SLA.0000000000005677
  • Yu YR, Rosenfeld EH, Chiou EH, et al. High-resolution manometric guidance during laparoscopic Heller myotomy: impact on quality of life and symptom severity for children with achalasia. J Pediatr Surg. 2019;54(5):1063–1068. doi: 10.1016/j.jpedsurg.2019.01.041
  • Jafri M, Alonso M, Kaul A, et al. Intraoperative manometry during laparoscopic Heller myotomy improves outcome in pediatric achalasia. J Pediatr Surg. 2008 Jan;43(1):66–70.
  • Caruso AM, Milazzo M, Tulone V, et al. High resolution manometry guidance during laparoscopic fundoplication in pediatric surgically “fragile” patients: preliminary report. Children (Basel). 2020 Nov 7;7(11):215. PMID: 33171722; PMCID: PMC7695016. doi: 10.3390/children7110215
  • Howk AA, Clifton MS, Garza JM, et al. Impedance planimetry (EndoFLIP) assisted laparoscopic esophagomyotomy in pediatric population. J Pediatr Surg. 2022;57(12):1000–1004. doi: 10.1016/j.jpedsurg.2022.05.004
  • Su B, Callahan ZM, Novak S, et al. Using impedance planimetry (EndoFLIP) to evaluate myotomy and predict outcomes after surgery for achalasia. J Gastrointest Surg. 2020;24(4):964–971. doi: 10.1007/s11605-020-04513-w
  • Altokhais T, Mandora H, Al-Qahtani A, et al. Robot-assisted Heller’s myotomy for achalasia in children. Comput Assist Surg (Abingdon). 2016;21(1):127–131. doi: 10.1080/24699322.2016.1217352
  • Milone M, Manigrasso M, Vertaldi S, et al. Robotic versus laparoscopic approach to treat symptomatic achalasia: systematic review with meta-analysis. Dis Esophagus. 2019;32(10):1–8. doi: 10.1093/dote/doz062
  • Ali AB, Khan NA, Nguyen DT, et al. Robotic and per-oral endoscopic myotomy have fewer technical complications compared to laparoscopic Heller myotomy. Surg Endosc. 2020;34(7):3191–3196. doi: 10.1007/s00464-019-07093-2
  • Boeckxstaens GE, Annese V, des Varannes SB, et al. European Achalasia Trial Investigators. Pneumatic dilation versus laparoscopic Heller’s myotomy for idiopathic achalasia. N Engl J Med. 2011 May 12;364(19):1807–1816. PMID: 21561346.doi: 10.1056/NEJMoa1010502
  • Salvador R, Spadotto L, Capovilla G, et al. Mucosal Perforation During Laparoscopic Heller Myotomy Has No Influence on Final Treatment Outcome. J Gastrointest Surg. 2016 Dec;20(12):1923–1930. Epub 2016 Sep 29. PMID: 27688213. doi: 10.1007/s11605-016-3276-y
  • Mencin AA, Sethi A, Barakat MT, et al. Peroral endoscopic myotomy (POEM) in children: a state of the art review. J Pediatr Gastroenterol Nutr. 2022;75(3):231–236. doi: 10.1097/MPG.0000000000003503
  • Schlottmann F, Luckett DJ, Fine J, et al. Laparoscopic Heller myotomy versus peroral endoscopic myotomy (POEM) for achalasia: a systematic review and meta-analysis. Ann Surg. 2018;267(3):451–460. doi: 10.1097/SLA.0000000000002311
  • Zhong C, Tan S, Huang S, et al. Clinical outcomes of peroral endoscopic myotomy for achalasia in children: a systematic review and meta-analysis. Dis Esophagus. 2021;34(4). doi: 10.1093/dote/doaa112
  • Nabi Z, Ramchandani M, Basha J, et al. POEM is a durable treatment in children and adolescents with Achalasia Cardia. Front Pediatr. 2022;10:812201. doi: 10.3389/fped.2022.812201
  • Nabi Z, Ramchandani M, Chavan R, et al. Peroral endoscopic myotomy in treatment-naïve achalasia patients versus prior treatment failure cases. Endoscopy. 2018;50(4):358–370. doi: 10.1055/s-0043-121632
  • Peng D, Tan Y, Li C, et al. Peroral endoscopic myotomy for pediatric achalasia: a retrospective analysis of 21 cases with a minimum follow-up of 5 years. Front Pediatr. 2022;10:845103. doi: 10.3389/fped.2022.845103
  • Nabi Z, Talukdar R, Chavan R, et al. Outcomes of per-oral endoscopic myotomy in children: a systematic review and meta-analysis. Dysphagia. 2022 Dec;37(6):1468–1481. Epub 2022 Jan 29. PMID: 35092485. doi: 10.1007/s00455-022-10409-5
  • Zhang XC, Li QL, Huang Y, et al. Peroral endoscopic myotomy using the posterior approach in an 11-month-old girl with achalasia, severe malnutrition, and recurrent pneumonia. Endoscopy. 2015;47 Suppl 1 UCTN(S 01):E480–2. doi: 10.1055/s-0034-1393156
  • Costantini A, Familiari P, Costantini M, et al. Poem versus laparoscopic Heller Myotomy in the treatment of esophageal achalasia: a case-control study from two high volume centers using the propensity score. J Gastrointest Surg. 2020 Mar;24(3):505–515. Epub 2019 Dec 17. PMID: 31848870. doi: 10.1007/s11605-019-04465-w
  • Werner YB, Hakanson B, Martinek J, et al. Endoscopic or surgical myotomy in patients with idiopathic achalasia. N Engl J Med. 2019 Dec 5;381(23):2219–2229. PMID: 31800987. doi: 10.1056/NEJMoa1905380
  • Holmstrom AL, Campagna RAJ, Cirera A, et al. Intraoperative use of FLIP is associated with clinical success following POEM for achalasia. Surg Endosc. 2021;35(6):3090–3096. doi: 10.1007/s00464-020-07739-6
  • Yeung F, Wong IYH, Chung PHY, et al. Peroral endoscopic myotomy with EndoFLIP and Double-Endoscope: novel techniques for achalasia in pediatric population. J Laparoendosc Adv Surg Tech A. 2018;28(3):343–347. doi: 10.1089/lap.2017.0268
  • Krishnan U, Mousa H, Dall’oglio L, et al. ESPGHAN-NASPGHAN guidelines for the evaluation and treatment of gastrointestinal and nutritional complications in children with esophageal atresia-tracheoesophageal fistula. J Pediatr Gastroenterol Nutr. 2016;63(5):550–570. doi: 10.1097/MPG.0000000000001401
  • Van Lennep M, Singendonk MMJ, Dall’oglio L, et al. Oesophageal atresia. Nat Rev Dis Primers. 2019;5(1):26. doi: 10.1038/s41572-019-0077-0
  • Tan Tanny SP, Roring JEA, Situmorang NY, et al. Preexisting neural factors that contribute to dysmotility in esophageal atresia: a systematic review. Pediatr Surg Int. 2022;39(1):68. doi: 10.1007/s00383-022-05353-2
  • Lemoine C, Aspirot A, Morris M, et al. Esophageal dysmotility is present before surgery in isolated tracheoesophageal fistula. J Pediatr Gastroenterol Nutr. 2015;60(5):642–644. doi: 10.1097/MPG.0000000000000667
  • Boleken M, Demirbilek S, Kirimiloglu H, et al. Reduced neuronal innervation in the distal end of the proximal esophageal atretic segment in cases of esophageal atresia with distal tracheoesophageal fistula. World J Surg. 2007;31(7):1512–1517. doi: 10.1007/s00268-007-9070-y
  • Faure C, Righini Grunder F. Dysmotility in esophageal atresia: pathophysiology, characterization, and treatment. Front Pediatr. 2017;5:130. doi: 10.3389/fped.2017.00130
  • Montgomery M, Escobar-Billing R, Hellström PM, et al. Impaired gastric emptying in children with repaired esophageal atresia: a controlled study. J Pediatr Surg. 1998;33(3):476–480. doi: 10.1016/S0022-3468(98)90091-4
  • Lindahl H, Rintala R. Long-term complications in cases of isolated esophageal atresia treated with esophageal anastomosis. J Pediatr Surg. 1995;30(8):1222–1223. doi: 10.1016/0022-3468(95)90028-4
  • Berthet S, Tenisch E, Miron MC, et al. Vascular anomalies associated with esophageal atresia and Tracheoesophageal Fistula. J Pediatr. 2015;166(5):1140–1144.e2. doi: 10.1016/j.jpeds.2015.01.038
  • van Lennep M, Chung E, Jiwane A, et al. Fundoplication in children with esophageal atresia: preoperative workup and outcome. Dis Esophagus. 2022;35(10). doi: 10.1093/dote/doac006
  • Dhaliwal J, Tobias V, Sugo E, et al. Eosinophilic esophagitis in children with esophageal atresia. Dis Esophagus. 2014;27(4):340–347. doi: 10.1111/dote.12119
  • Upendran Y, Leach ST, Singh H, et al. Pepsin as a marker of reflux aspiration in children with esophageal atresia: a pilot study. Front Pediatr. 2020;8:94. doi: 10.3389/fped.2020.00094
  • Fortunato JE, D’Agostino RB Jr., Lively MO. Pepsin in saliva as a biomarker for oropharyngeal reflux compared with 24-hour esophageal impedance/pH monitoring in pediatric patients. Neurogastroenterol Motil. 2017;29(2). doi: 10.1111/nmo.12936
  • Woodland P, Singendonk MMJ, Ooi J, et al. Measurement of salivary pepsin to detect gastroesophageal reflux disease is not ready for clinical application. Clin Gastroenterol Hepatol. 2019;17(3):563–565. doi: 10.1016/j.cgh.2018.05.016
  • Destro F, Costanzo S, Durante E, et al. Utility of functional lumen imaging probe in long-term follow-up of children with esophageal atresia: a single-center retrospective study. Children (Basel). 2022;9(10):1426. doi: 10.3390/children9101426
  • Ten Kate CA, Vlot J, IJ H, et al. Intralesional steroid injections to prevent refractory strictures in patients with oesophageal atresia: study protocol for an international, multicentre randomised controlled trial (STEPS-EA trial). BMJ Open. 2019;9(12):e033030. doi: 10.1136/bmjopen-2019-033030
  • van Hal ARL, Pulvirenti R, den Hartog F, et al. The safety of Intralesional steroid injections in young children and their effectiveness in anastomotic esophageal strictures—A meta-analysis and systematic review. Front Pediatr. 2021;9:825030. doi: 10.3389/fped.2021.825030
  • Ngo PD, Kamran A, Clark SJ, et al. Intralesional steroid injection therapy for esophageal anastomotic stricture following esophageal atresia repair. J Pediatr Gastroenterol Nutr. 2020;70(4):462–467. doi: 10.1097/MPG.0000000000002562
  • Madadi-Sanjani O, Zimmer J, Gosemann JH, et al. Topical Mitomycin C application in pediatric patients with recurrent esophageal strictures-report on unfavorable results. Eur J Pediatr Surg. 2018;28(6):539–546. doi: 10.1055/s-0037-1615278
  • Ley D, Bridenne M, Gottrand F, et al. Efficacy and safety of the local application of mitomycin C to recurrent esophageal strictures in children. J Pediatr Gastroenterol Nutr. 2019;69(5):528–532. doi: 10.1097/MPG.0000000000002445
  • Vergouwe FWT, IJ H, Biermann K, et al. High prevalence of Barrett’s esophagus and esophageal squamous cell carcinoma after repair of esophageal atresia. Clin Gastroenterol Hepatol. 2018;16(4):513–521.e6. doi: 10.1016/j.cgh.2017.11.008
  • Tullie L, Kelay A, Bethell GS, et al. Barrett’s oesophagus and oesophageal cancer following oesophageal atresia repair: a systematic review. BJS Open. 2021;5(4). doi: 10.1093/bjsopen/zrab069
  • Vergouwe FW, Gottrand M, Wijnhoven BP, et al. Four cancer cases after esophageal atresia repair: time to start screening the upper gastrointestinal tract. World J Gastroenterol. 2018;24(9):1056–1062. doi: 10.3748/wjg.v24.i9.1056
  • Krishnan U, Dumont MW, Slater H, et al. The international network on oesophageal atresia (INoEA) consensus guidelines on the transition of patients with oesophageal atresia–tracheoesophageal fistula. Nat Rev Gastroenterol Hepatol. 2023 Jun 7;20(11):735–755. Epub ahead of print. PMID: 37286639. doi:10.1038/s41575-023-00789-w
  • Totonelli G, Maghsoudlou P, Fishman JM, et al. Esophageal tissue engineering: a new approach for esophageal replacement. World J Gastroenterol. 2012;18(47):6900–6907. doi: 10.3748/wjg.v18.i47.6900
  • Orlando G, Farney AC, Iskandar SS, et al. Production and implantation of renal extracellular matrix scaffolds from porcine kidneys as a platform for renal bioengineering investigations. Ann Surg. 2012;256(2):363–370. doi: 10.1097/SLA.0b013e31825a02ab
  • Maghsoudlou P, Georgiades F, Tyraskis A, et al. Preservation of micro-architecture and angiogenic potential in a pulmonary acellular matrix obtained using intermittent intra-tracheal flow of detergent enzymatic treatment. Biomaterials. 2013;34(28):6638–6648. doi: 10.1016/j.biomaterials.2013.05.015
  • Elliott MJ, De Coppi P, Speggiorin S, et al. Stem-cell-based, tissue engineered tracheal replacement in a child: a 2-year follow-up study. Lancet. 2012;380(9846):994–1000. doi: 10.1016/S0140-6736(12)60737-5
  • Model L, Wiesel O. A narrative review of esophageal tissue engineering and replacement: where are we? Ann Transl Med. 2021;9(10):910.
  • Lu PL, Moore-Clingenpeel M, Yacob D, et al. The rising cost of hospital care for children with gastroparesis: 2004-2013. Neurogastroenterol Motil. 2016;28(11):1698–1704. doi: 10.1111/nmo.12869
  • Borrelli O, Salvia G, Mancini V, et al. Evolution of gastric electrical features and gastric emptying in children with Duchenne and Becker muscular dystrophy. Am J Gastroenterol. 2005;100(3):695–702. doi: 10.1111/j.1572-0241.2005.41303.x
  • Kovacic K, Elfar W, Rosen JM, et al. Update on pediatric gastroparesis: a review of the published literature and recommendations for future research. Neurogastroenterol Motil. 2020;32(3):e13780. doi: 10.1111/nmo.13780
  • Hynes MC, Yik YI, Veysey D, et al. Gastrointestinal transit patterns identified in children with intractable chronic constipation using scintigraphy: experience of over 1000 cases. Gastroenterology. 2017;152(5):S515. doi: 10.1016/S0016-5085(17)31898-X
  • Sanger GJ, Andrews PLR. Review article: an analysis of the pharmacological rationale for selecting drugs to inhibit vomiting or increase gastric emptying during treatment of gastroparesis. Aliment Pharmacol Ther. 2023;57(9):962–978.
  • Machado RS, Reber M, Patrício FR, et al. Gastric emptying of solids is slower in functional dyspepsia unrelated to Helicobacter pylori infection in female children and teenagers. J Pediatr Gastroenterol Nutr. 2008;46(4):403–408. doi: 10.1097/MPG.0b013e318159224e
  • Altepeter TA, Shaffer S. Yield of endoscopy in pediatric gastroparesis. J Pediatr Gastroenterol Nutr. 2017;65(1):22–25. doi: 10.1097/MPG.0000000000001440
  • Wong GK, Shulman RJ, Chiou EH, et al. Decreased relative diagnostic yield of esophagogastroduodenoscopy in children with gastroparesis. J Clin Gastroenterol. 2014;48(3):231–235. doi: 10.1097/MCG.0b013e318299c8dd
  • Kwatra NS, Shalaby-Rana E, Andrich MP, et al. Gastric emptying of milk in infants and children up to 5 years of age: normative data and influencing factors. Pediatr Radiol. 2020;50(5):689–697. doi: 10.1007/s00247-020-04614-3
  • Orsagh-Yentis DK, Bai S, Bobbey A, et al. Spirulina breath test indicates differences in gastric emptying based on age, gender, and BMI. Neurogastroenterol Motil. 2021;33(6):e14079. doi: 10.1111/nmo.14079
  • Hauser B, Roelants M, De Schepper J, et al. Gastric emptying of solids in children: reference values for the (13) C-octanoic acid breath test. Neurogastroenterol Motil. 2016;28(10):1480–1487. doi: 10.1111/nmo.12845
  • Shakir AK, Altaf MA. Azithromycin induces migrating motor complexes in pediatric patients undergoing antroduodenal motility studies. J Pediatr Pharmacol Ther. 2018;23(5):390–394. doi: 10.5863/1551-6776-23.5.390
  • Rodriguez L, Irani K, Jiang H, et al. Clinical presentation, response to therapy, and outcome of gastroparesis in children. J Pediatr Gastroenterol Nutr. 2012;55(2):185–190. doi: 10.1097/MPG.0b013e318248ed3f
  • Franzese A, Borrelli O, Corrado G, et al. Domperidone is more effective than cisapride in children with diabetic gastroparesis. Aliment Pharmacol Ther. 2002;16(5):951–957. doi: 10.1046/j.1365-2036.2002.01240.x
  • Rodriguez L, Diaz J, Nurko S. Safety and efficacy of cyproheptadine for treating dyspeptic symptoms in children. J Pediatr. 2013;163(1):261–267. doi: 10.1016/j.jpeds.2012.12.096
  • Iglesias-Escabi IM, Kleesattel D, McDaniel LS, et al. Effect of Mirtazapine on nausea in children with functional nausea and functional dyspepsia postprandial distress syndrome. Paediatr Drugs. 2022;24(2):155–161. doi: 10.1007/s40272-022-00494-2
  • Jacob D, Busciglio I, Burton D, et al. Effects of NK1 receptors on gastric motor functions and satiation in healthy humans: results from a controlled trial with the NK1 antagonist aprepitant. Am J Physiol Gastrointest Liver Physiol. 2017;313(5):G505–g10. doi: 10.1152/ajpgi.00197.2017
  • Pasricha PJ, Yates KP, Sarosiek I, et al. Aprepitant has mixed effects on nausea and reduces other symptoms in patients with gastroparesis and related disorders. Gastroenterology. 2018;154(1):65–76.e11. doi: 10.1053/j.gastro.2017.08.033
  • Cristofori F, Thapar N, Saliakellis E, et al. Efficacy of the neurokinin-1 receptor antagonist aprepitant in children with cyclical vomiting syndrome. Aliment Pharmacol Ther. 2014;40(3):309–317. doi: 10.1111/apt.12822
  • Carbone F, Vanuytsel T, Tack J. The effect of prucalopride on gastric sensorimotor function and satiation in healthy volunteers. Neurogastroenterol Motil. 2021;33(8):e14083. doi: 10.1111/nmo.14083
  • Carbone F, Van den Houte K, Clevers E, et al. Prucalopride in gastroparesis: a randomized placebo-controlled crossover study. Am J Gastroenterol. 2019;114(8):1265–1274. doi: 10.14309/ajg.0000000000000304
  • Hirsch S, Nurko S, Mitchell P, et al. Prucalopride for treatment of upper gastrointestinal symptoms in children. Paediatr Drugs. 2022;24(1):73–81. doi: 10.1007/s40272-021-00489-5
  • Escobar-Serna DP, Peralta-Palmezano FJ, Peralta-Palmezano JJ. A case report of prucalopride treatment in pediatric gastroparesis: a novel therapy. Arch Argent Pediatr. 2022;120(2):e98–e101.
  • TSC N, Putta N, Kwatra NS, et al. Pediatric solid gastric emptying scintigraphy: normative value guidelines and nonstandard meal alternatives. Am J Gastroenterol. 2020;115(11):1830–1839. doi: 10.14309/ajg.0000000000000831
  • Mearin F, Camilleri M, Malagelada JR. Pyloric dysfunction in diabetics with recurrent nausea and vomiting. Gastroenterology. 1986;90(6):1919–1925. doi: 10.1016/0016-5085(86)90262-3
  • Friedenberg FK, Palit A, Parkman HP, et al. Botulinum toxin a for the treatment of delayed gastric emptying. Am J Gastroenterol. 2008;103(2):416–423. doi: 10.1111/j.1572-0241.2007.01676.x
  • Arts J, Holvoet L, Caenepeel P, et al. Clinical trial: a randomized-controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis. Aliment Pharmacol Ther. 2007;26(9):1251–1258. doi: 10.1111/j.1365-2036.2007.03467.x
  • Pasricha TS, Pasricha PJ. Botulinum Toxin Injection for Treatment of Gastroparesis. Gastrointest Endosc Clin N Am. 2019;29(1):97–106. doi: 10.1016/j.giec.2018.08.007
  • Coleski R, Anderson MA, Hasler WL. Factors associated with symptom response to pyloric injection of botulinum toxin in a large series of gastroparesis patients. Dig Dis Sci. 2009;54(12):2634–2642. doi: 10.1007/s10620-008-0660-9
  • Bensen GP, Rutherford CC, Gardner TB. Systemic botulism toxicity caused by pyloric botox injection to treat Gastroparesis. Case Rep Gastroenterol. 2020;14(2):373–376. doi: 10.1159/000508854
  • Rodriguez L, Rosen R, Manfredi M, et al. Endoscopic intrapyloric injection of botulinum toxin a in the treatment of children with gastroparesis: a retrospective, open-label study. Gastrointest Endosc. 2012;75(2):302–309. doi: 10.1016/j.gie.2011.09.042
  • Ezaizi Y, Hasan B, Manini ML, et al. Intrapyloric botulinum toxin a injection for gastroparesis and functional upper gastrointestinal symptoms in children: mayo clinic experience, review of the literature, and meta-analysis. Paediatr Drugs. 2022;24(5):539–545. doi: 10.1007/s40272-022-00518-x
  • Mercier C, Ley D, Aumar M, et al. Comparison of symptom control in pediatric gastroparesis using endoscopic pyloric botulinum toxin injection and dilatation. J Pediatr Gastroenterol Nutr. 2021;73(3):314–318. doi: 10.1097/MPG.0000000000003195
  • Hirsch S, Nurko S, Liu E, et al. A prospective study of intrapyloric botulinum toxin and EndoFLIP in children with nausea and vomiting. Neurogastroenterol Motil. 2022;34(11):e14428. doi: 10.1111/nmo.14428
  • Khashab MA, Stein E, Clarke JO, et al. Gastric peroral endoscopic myotomy for refractory gastroparesis: first human endoscopic pyloromyotomy (with video). Gastrointest Endosc. 2013;78(5):764–768. doi: 10.1016/j.gie.2013.07.019
  • Li P, Ma B, Gong S, et al. Gastric per-Oral Endoscopic Myotomy for Refractory Gastroparesis: A Meta-Analysis. J Gastrointest Surg. 2021;25(5):1108–1116. doi: 10.1007/s11605-020-04520-x
  • Vosoughi K, Ichkhanian Y, Benias P, et al. Gastric per-oral endoscopic myotomy (G-POEM) for refractory gastroparesis: results from an international prospective trial. Gut. 2022;71(1):25–33. doi: 10.1136/gutjnl-2020-322756
  • Zhang H, Liu Z, Ma L, et al. Gastric peroral endoscopic pyloromyotomy for infants with congenital hypertrophic pyloric stenosis. Am J Gastroenterol. 2023;118(3):465–474. doi: 10.14309/ajg.0000000000001973
  • Islam S, McLaughlin J, Pierson J, et al. Long-term outcomes of gastric electrical stimulation in children with gastroparesis. J Pediatr Surg. 2016;51(1):67–71. doi: 10.1016/j.jpedsurg.2015.10.015
  • Ducrotte P, Coffin B, Bonaz B, et al. Gastric electrical stimulation reduces refractory vomiting in a randomized crossover trial. Gastroenterology. 2020;158(3):506–514.e2. doi: 10.1053/j.gastro.2019.10.018
  • Thapar N, Saliakellis E, Benninga MA, et al. Paediatric intestinal pseudo-obstruction: evidence and consensus-based recommendations from an ESPGHAN-Led expert group. J Pediatr Gastroenterol Nutr. 2018;66(6):991–1019. doi: 10.1097/MPG.0000000000001982
  • Muto M, Matsufuji H, Tomomasa T, et al. Pediatric chronic intestinal pseudo-obstruction is a rare, serious, and intractable disease: a report of a nationwide survey in Japan. J Pediatr Surg. 2014;49(12):1799–1803. doi: 10.1016/j.jpedsurg.2014.09.025
  • Vargas JH, Sachs P, Ament ME. Chronic intestinal pseudo-obstruction syndrome in pediatrics. Results of a national survey by members of the North American Society of pediatric Gastroenterology and nutrition. J Pediatr Gastroenterol Nutr. 1988;7(3):323–332. doi: 10.1097/00005176-198805000-00003
  • Schwankovsky L, Mousa H, Rowhani A, et al. Quality of life outcomes in congenital chronic intestinal pseudo-obstruction. Dig Dis Sci. 2002;47(9):1965–1968. doi: 10.1023/A:1019644022606
  • Batra S, Rahman S, Rana MS, et al. Epidemiology and healthcare utilization of inpatient admissions in children with pediatric intestinal pseudo-obstruction. Neurogastroenterol Motil. 2020;32(4):e13781. doi: 10.1111/nmo.13781
  • Chanpong A, Borrelli O, Thapar N. Hirschsprung disease and Paediatric Intestinal Pseudo-obstruction. Best Pract Res Clin Gastroenterol. Best Pract Res Clin Gastroenterol. 2022;56-57:101765.
  • Saliakellis E, Turcotte M-C, Faure C, et al. Pediatric Intestinal Pseudo-Obstruction. In: Faure C, Thapar N Di Lorenzo Ceditors. Pediatric neurogastroenterology: gastrointestinal motility disorders and disorders of gut brain interaction in children. Cham: Springer International Publishing; 2022. p. 333–353.
  • Nham S, Nguyen ATM, Holland AJA. Paediatric intestinal pseudo-obstruction: a scoping review. Eur J Pediatr. 2022;181(7):2619–2632. doi: 10.1007/s00431-021-04365-9
  • Chanpong A, Cronin H, Rampling D, et al. Enhancing the utility of antroduodenal manometry in pediatric intestinal pseudo-obstruction. Neurogastroenterol Motil. 2022;34(5):e14259. doi: 10.1111/nmo.14259
  • Chanpong AME, Biassoni L, Easty M, et al. ESPGHAN 54th annual meeting abstracts: small-bowel transit scintigraphy in children with paediatric intestinal pseudo-obstruction. J Pediatr Gastroenterol Nutr. 2022;74(S2):41.
  • Di Nardo G, Viscogliosi F, Esposito F, et al. Pyridostigmine in pediatric intestinal pseudo-obstruction: case report of a 2-year old girl and literature review. J Neurogastroenterol Motil. 2019;25(4):508–514. doi: 10.5056/jnm19078
  • Turcotte M-C, Faure C. Pediatric intestinal pseudo-obstruction: progress and challenges. Front Pediatr. 2022;10:10. doi: 10.3389/fped.2022.837462
  • Mutalib M, Kammermeier J, Vora R, et al. Prucalopride in intestinal pseudo obstruction, paediatric experience and systematic review. Acta Gastroenterol Belg. 2021;84(3):429–434. doi: 10.51821/84.3.002
  • Di Lorenzo C, Lucanto C, Flores AF, et al. Effect of octreotide on gastrointestinal motility in children with functional gastrointestinal symptoms. J Pediatr Gastroenterol Nutr. 1998;27(5):508–512. doi: 10.1097/00005176-199811000-00002
  • Damrongmanee A, El-Chammas K, Fei L, et al. Effects of provocative testing on phase III migrating motor complex in children. J Pediatr Gastroenterol Nutr. 2021 Oct 1;73(4):507–512. doi: 10.1097/MPG.0000000000003217
  • Ambartsumyan L, Flores A, Nurko S, et al. Utility of octreotide in advancing enteral feeds in children with chronic intestinal pseudoobstruction. Paediatr Drugs. 2016;18(5):387–392. doi: 10.1007/s40272-016-0189-x
  • Di Nardo G, Manca MB, Iannicelli E, et al. Percutaneous endoscopic gastrojejunostomy in pediatric intestinal pseudo-obstruction. Nutrition. 2021;86:111174. doi: 10.1016/j.nut.2021.111174
  • Sogawa H, Costa G, Armanyous S, et al. Twenty years of gut transplantation for chronic intestinal pseudo-obstruction: technical innovation, long-term outcome, quality of life, and disease recurrence. Ann Surg. 2021;273(2):325–333. doi: 10.1097/SLA.0000000000003265
  • Zaidman I, Elhasid R, Gefen A, et al. Hematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalopathy: a single-center experience underscoring the multiple factors involved in the prognosis. Pediatr Blood Cancer. 2021;68(5):e28926. doi: 10.1002/pbc.28926
  • Gu L, Ding C, Tian H, et al. Serial frozen fecal microbiota transplantation in the treatment of chronic intestinal pseudo-obstruction: a preliminary study. J Neurogastroenterol Motil. 2017;23(2):289–297. doi: 10.5056/jnm16074
  • Rajindrajith S, Devanarayana NM. Constipation in children: novel insight into epidemiology, pathophysiology and management. J Neurogastroenterol Motil. 2011;17(1):35–47. doi: 10.5056/jnm.2011.17.1.35
  • Cortesini C, Cianchi F, Infantino A, et al. Nitric oxide synthase and VIP distribution in enteric nervous system in idiopathic chronic constipation. Dig Dis Sci. 1995;40(11):2450–2455. doi: 10.1007/BF02063253
  • He CL, Burgart L, Wang L, et al. Decreased interstitial cell of Cajal volume in patients with slow-transit constipation. Gastroenterology. 2000;118(1):14–21. doi: 10.1016/S0016-5085(00)70409-4
  • Hutson JM, Chow CW, Borg J. Intractable constipation with a decrease in substance P-immunoreactive fibres: is it a variant of intestinal neuronal dysplasia? J Pediatr Surg. 1996;31(4):580–583. doi: 10.1016/S0022-3468(96)90501-1
  • Rybak A, Martinelli M, Thapar N, et al. Colonic function investigations in children: review by the ESPGHAN motility working group. J Pediatr Gastroenterol Nutr. 2022;74(5):681–692. doi: 10.1097/MPG.0000000000003429
  • Rodriguez L, Heinz N, Nurko S. Utility of colon manometry in guiding therapy and predicting need for surgery in children with defecation disorders. J Pediatr Gastroenterol Nutr. 2020;70(2):232–237. doi: 10.1097/MPG.0000000000002504
  • Gupta A, Basson S, Borrelli O, et al. Surgically treated intractable constipation in children evaluated with colonic manometry. J Pediatr Surg. 2020;55(2):265–268. doi: 10.1016/j.jpedsurg.2019.10.046
  • Gutiérrez C, Marco A, Nogales A, et al. Total and segmental colonic transit time and anorectal manometry in children with chronic idiopathic constipation. J Pediatr Gastroenterol Nutr. 2002;35(1):31–38. doi: 10.1097/00005176-200207000-00008
  • Chanpong A, Thapar N. Paediatric neurogastroenterology and motility: moving rapidly into the future. J Pediatr Gastroenterol Nutr. 2023;76(5):547–552.
  • Wiklendt L, Costa M, Scott MS, et al. Automated analysis using a bayesian functional mixed-effects model with gaussian process responses for wavelet spectra of spatiotemporal colonic manometry signals. Front Physiol. 2021;11:11. doi: 10.3389/fphys.2020.605066
  • Vriesman MH, de Jonge CS, Kuizenga-Wessel S, et al. Simultaneous assessment of colon motility in children with functional constipation by cine-MRI and colonic manometry: a feasibility study. Eur Radiol Exp. 2021;5(1):8. doi: 10.1186/s41747-021-00205-5
  • Hasosah M. Chronic refractory constipation in children: think beyond stools. Glob Pediatr Health. 2021;8:2333794x211048739. doi: 10.1177/2333794X211048739
  • Sajid MS, Hebbar M, Baig MK, et al. Use of prucalopride for chronic constipation: a systematic review and meta-analysis of published randomized, controlled trials. J Neurogastroenterol Motil. 2016;22(3):412–422. doi: 10.5056/jnm16004
  • Mugie SM, Korczowski B, Bodi P, et al. Prucalopride is no more effective than placebo for children with functional constipation. Gastroenterology. 2014;147(6):1285–1295.e1. doi: 10.1053/j.gastro.2014.09.005
  • Jamie M, Andrew B, Timothy B, et al. G11 prucalopride for treatment refractory constipation in children: a single tertiary centre experience. Frontline Gastroenterol. 2022;13(Suppl 1):A22.
  • Lembo AJ, Schneier HA, Shiff SJ, et al. Two randomized trials of linaclotide for chronic constipation. N Engl J Med. 2011;365(6):527–536. doi: 10.1056/NEJMoa1010863
  • Baaleman DF, Gupta S, Benninga MA, et al. The use of Linaclotide in children with functional constipation or irritable bowel syndrome: a retrospective chart review. Paediatr Drugs. 2021;23(3):307–314. doi: 10.1007/s40272-021-00444-4
  • Patel S, Hopson P, Bornstein J, et al. Impact of transanal irrigation device in the management of children with fecal incontinence and constipation. J Pediatr Gastroenterol Nutr. 2020;71(3):292–297. doi: 10.1097/MPG.0000000000002785
  • Iacona R, Ramage L, Malakounides G. Current state of neuromodulation for constipation and fecal incontinence in children: a systematic review. Eur J Pediatr Surg. 2019;29(6):495–503. doi: 10.1055/s-0038-1677485
  • Liu J, Gu L, Zhang M, et al. The fecal microbiota transplantation: a remarkable clinical therapy for slow transit constipation in future. Front Cell Infect Microbiol. 2021;11:11. doi: 10.3389/fcimb.2021.732474
  • Pacitti D, Bax BE. The development of an in vitro cerebral organoid model for investigating the pathomolecular mechanisms associated with the central nervous system involvement in mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). Nucleosides Nucleotides Nucleic Acids. 2018;37(11):603–617. doi: 10.1080/15257770.2018.1492139
  • Schlieve CR, Fowler KL, Thornton M, et al. Neural crest cell implantation restores enteric nervous system function and alters the gastrointestinal transcriptome in human tissue-engineered small intestine. Stem Cell Rep. 2017;9(3):883–896. doi: 10.1016/j.stemcr.2017.07.017

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.